113 related articles for article (PubMed ID: 22549500)
1. Oral aripiprazole-induced severe hypoglycemia.
Mondal S; Saha I; Das S; Ganguly A; Ghosh A; Kumar Das A
Ther Drug Monit; 2012 Jun; 34(3):245-8. PubMed ID: 22549500
[TBL] [Abstract][Full Text] [Related]
2. Torsades de pointes after administration of low-dose aripiprazole.
Nelson S; Leung JG
Ann Pharmacother; 2013 Feb; 47(2):e11. PubMed ID: 23362038
[TBL] [Abstract][Full Text] [Related]
3. Aripiprazole for the treatment of psychoses in institutionalized patients with Alzheimer dementia: a multicenter, randomized, double-blind, placebo-controlled assessment of three fixed doses.
Mintzer JE; Tune LE; Breder CD; Swanink R; Marcus RN; McQuade RD; Forbes A
Am J Geriatr Psychiatry; 2007 Nov; 15(11):918-31. PubMed ID: 17974864
[TBL] [Abstract][Full Text] [Related]
4. High dosage of aripiprazole-induced dysphagia.
Lin TW; Lee BS; Liao YC; Chiu NY; Hsu WY
Int J Eat Disord; 2012 Mar; 45(2):305-6. PubMed ID: 21541978
[TBL] [Abstract][Full Text] [Related]
5. Aripiprazole for drug-naive or antipsychotic-short-exposure subjects with ultra-high risk state and first-episode psychosis: an open-label study.
Liu CC; Chien YL; Hsieh MH; Hwang TJ; Hwu HG; Liu CM
J Clin Psychopharmacol; 2013 Feb; 33(1):18-23. PubMed ID: 23277261
[TBL] [Abstract][Full Text] [Related]
6. Mirtazapine monotherapy versus combination therapy with mirtazapine and aripiprazole in depressed patients without psychotic features: a 4-week open-label parallel-group study.
Schüle C; Baghai TC; Eser D; Hecht S; Hermisson I; Born C; Häfner S; Nothdurfter C; Rupprecht R
World J Biol Psychiatry; 2007; 8(2):112-22. PubMed ID: 17455104
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of oral aripiprazole compared with haloperidol in patients transitioning from acute treatment with intramuscular formulations.
Daniel DG; Currier GW; Zimbroff DL; Allen MH; Oren D; Manos G; McQuade R; Pikalov AA; Crandall DT
J Psychiatr Pract; 2007 May; 13(3):170-7. PubMed ID: 17522560
[TBL] [Abstract][Full Text] [Related]
8. A case of aripiprazole and tardive dyskinesia.
Abbasian C; Power P
J Psychopharmacol; 2009 Mar; 23(2):214-5. PubMed ID: 18515468
[TBL] [Abstract][Full Text] [Related]
9. Aripiprazole induced transient myopia: a case report and review of literature.
Nair AG; Nair AG; George RJ; Biswas J; Gandhi RA
Cutan Ocul Toxicol; 2012 Mar; 31(1):74-6. PubMed ID: 21830909
[TBL] [Abstract][Full Text] [Related]
10. Acute dystonia with low-dosage aripiprazole in Tourette's disorder.
Fountoulakis KN; Siamouli M; Kantartzis S; Panagiotidis P; Iacovides A; Kaprinis GS
Ann Pharmacother; 2006 Apr; 40(4):775-7. PubMed ID: 16569800
[TBL] [Abstract][Full Text] [Related]
11. Increased aripiprazole concentrations in an HIV-positive male concurrently taking duloxetine, darunavir, and ritonavir.
Aung GL; O'Brien JG; Tien PG; Kawamoto LS
Ann Pharmacother; 2010 Nov; 44(11):1850-4. PubMed ID: 20978219
[TBL] [Abstract][Full Text] [Related]
12. Improvement of tardive dyskinesia and dystonia associated with aripiprazole following a switch to quetiapine: case report and review of the literature.
Ono S; Suzuki Y; Shindo M; Endo T; Fukui N; Sugai T; Someya T
J Clin Pharm Ther; 2012 Jun; 37(3):370-2. PubMed ID: 22023382
[TBL] [Abstract][Full Text] [Related]
13. Intramuscular aripiprazole or haloperidol and transition to oral therapy in patients with agitation associated with schizophrenia: sub-analysis of a double-blind study.
Andrezina R; Marcus RN; Oren DA; Manos G; Stock E; Carson WH; McQuade RD
Curr Med Res Opin; 2006 Nov; 22(11):2209-19. PubMed ID: 17076982
[TBL] [Abstract][Full Text] [Related]
14. Predictors of clinical worsening after a switch to aripiprazole in patients with schizophrenia: a 1-year naturalistic follow-up study.
Takeuchi H; Uchida H; Suzuki T; Watanabe K; Kashima H
J Clin Psychopharmacol; 2009 Aug; 29(4):394-5. PubMed ID: 19593185
[No Abstract] [Full Text] [Related]
15. Neuroleptic malignant syndrome with aripiprazole and lithium: a case report.
Ali S; Pearlman RL; Upadhyay A; Patel P
J Clin Psychopharmacol; 2006 Aug; 26(4):434-6. PubMed ID: 16855467
[No Abstract] [Full Text] [Related]
16. Symptomatic bradycardia with oral aripiprazole and oral ziprasidone.
Snarr BS; Phan SV; Garner A; VandenBerg AM; Barth KS
Ann Pharmacother; 2010 Apr; 44(4):760-3. PubMed ID: 20215494
[TBL] [Abstract][Full Text] [Related]
17. A randomized, open-label comparison of 2 switching strategies to aripiprazole treatment in patients with schizophrenia: add-on, wait, and tapering of previous antipsychotics versus add-on and simultaneous tapering.
Takeuchi H; Suzuki T; Uchida H; Nakajima S; Nomura K; Kikuchi T; Manki H; Watanabe K; Kashima H
J Clin Psychopharmacol; 2008 Oct; 28(5):540-3. PubMed ID: 18794650
[TBL] [Abstract][Full Text] [Related]
18. Aripiprazole intramuscular depot as maintenance treatment in patients with schizophrenia: a 52-week, multicenter, randomized, double-blind, placebo-controlled study.
Kane JM; Sanchez R; Perry PP; Jin N; Johnson BR; Forbes RA; McQuade RD; Carson WH; Fleischhacker WW
J Clin Psychiatry; 2012 May; 73(5):617-24. PubMed ID: 22697189
[TBL] [Abstract][Full Text] [Related]
19. An open-label assessment of aripiprazole in the treatment of PTSD.
Robert S; Hamner MB; Durkalski VL; Brown MW; Ulmer HG
Psychopharmacol Bull; 2009; 42(1):69-80. PubMed ID: 19204652
[TBL] [Abstract][Full Text] [Related]
20. A randomized, double-blind, placebo-controlled study of aripiprazole for the treatment of psychosis in nursing home patients with Alzheimer disease.
Streim JE; Porsteinsson AP; Breder CD; Swanink R; Marcus R; McQuade R; Carson WH
Am J Geriatr Psychiatry; 2008 Jul; 16(7):537-50. PubMed ID: 18591574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
